Pharmacomechanical thrombolysis does not lower risk of post-thrombotic syndrome: The ATTRACT trial

1. Patients with proximal deep venous thrombosis (DVT) experience similar rates of post-thrombotic syndrome (PTS) when treated with pharmacomechanical catheter-directed thrombolysis (PCDT) plus anticoagulation...

Value-based payment modifier program not associated with differences in performance program measures

1. Taking into account additional patient characteristics largely influenced performance differences between practices serving high and low risk patients. 2. The value-based payment modifier program...

High readmission rates after revascularization for peripheral arterial disease

1. Of patients with peripheral arterial disease (PAD), 17.6% were readmitted within 30 days after being discharged following peripheral arterial revascularization. 2. After standardizing readmission...

Administering naloxone for opioid overdose reversal in out-of-hospital settings appears to be safe and...

1. For reversing opioid overdose, intranasal naloxone of a higher concentration (2 mg/mL) seems to have a similar efficacy to intramuscular naloxone. 2. Lack of...

Brodmann area 25 may have role in causing peri-ictal systolic hypotension in patients with...

1. In this case series of 12 patients with intractable epilepsy, deep brain electrical stimulation of Brodmann area 25 resulted in significant and consistent...

Clinician denial of certain patient requests linked with decreased satisfaction

1. In an observational study of a single family practice clinic, clinician-patient interactions in which a request was denied was linked to lower patient...

Multiple treatment trajectories exist in adolescent depression

1. In this longitudinal retrospective cohort study, there were multiple treatment trajectories identified among youth with depression. 2. Psychotherapy monotherapy was associated with the lowest...

Erenumab linked to decreased episodic migraine frequency: The STRIVE trial

1. Monthly injections of erenumab were associated with reduced migraine frequency, decreased use of acute migraine medication, and decreased migraine burden on daily activities...

Fremanezumab reduces headache frequency in patients with chronic migraine

1. Patients with chronic migraine receiving fremanezumab had significantly fewer migraines and headaches than those receiving placebo after 12 weeks of treatment. 2. Injection-site reactions,...

Evidence-based supportive therapy for bronchiolitis varies significantly between hospitals

1. Less than 75% of study infants hospitalized with acute bronchiolitis received the current recommended treatment, evidence-based supportive therapies (EBST), with significant variation between...
licensing as small

Popular